VenoValve to be Featured During Presentation at the 47th Annual Charing Cross Symposium

IRVINE, CA / ACCESS Newswire / April 23, 2025 / enVVeno Medical Corporation (Nasdaq:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of deep venous disease, today announced that the VenoValve will be …
Jetzt den vollständigen Artikel lesen